ArticleClinical rheumatology2023

Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.

Lucía Vallez-Valero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.